Cell ReportsBioinformaticsPeer-reviewed journal article
Genetic dependencies associated with transcription factor activities in human cancer cell lines
Venu ThatikondaiD, Verena SupperiD, Johannes Wachter, Onur Kaya, Anju Kombara, Ceren Bilgilier, Madhwesh C. Ravichandran, Jesse LippiD, Rahul SharmaiD, Lukas Badertscher, Andrew S. BoghossianiD, Matthew G. ReesiD, Melissa M. RonaniD, Jennifer A. RothiD, Sarah GroscheiD, Ralph A. NeumülleriD, Barbara MairiD, Federico MauriiD, Alexandra PopaiD
Abstract
Transcription factors (TFs) are key components of the aberrant transcriptional programs in cancer cells. In this study, we used TF activity (TFa), inferred from the downstream regulons as a potential biomarker to identify associated genetic vulnerabilities in cancer cells. Our linear model framework, integrating TFa and genome-wide CRISPR knockout datasets identified 1,770 candidate TFa-target pairs across different cancer types and assessed their survival impact in patient data. As a proof of concept, through inhibitor screens and genetic depletion assays in cell lines, we validated the dependency of cell lines on predicted targets linked to TEAD1, the most prominent TF from our analysis. Overall, these candidate pairs represent an attractive resource for early-stage targets and drug discovery programs in oncology.
- organism: human
- assay: CRISPR screen
- research focus: drug response / drug discovery
- approach: statistical model
- Citations
- 3
- FWCI
- 0.41
- Field percentile
- top 49%
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Transcription factor activities enhance markers of drug response in cancer
L. Garcia-Alonso, F. Iorio, … J. Saez-Rodriguez·bioRxiv·Apr 21, 2017
- Lineage specific core-regulatory circuits determine gene essentiality in cancer cells
Benedikt Rauscher, Luisa Henkel, … Michael Boutros·bioRxiv·Apr 16, 2019
- Cancer target discovery enabled by transcriptome-based virtual CRISPR screening
Ananthan Sadagopan, Bingchen Li, … Srinivas Raghavan Viswanathan·bioRxiv·Oct 24, 2024
- Deciphering drug response and phenotypic heterogeneity of cancer cells using gene ensembles of regulatory units defined by chromatin domains
- A large-scale cancer-specific protein-DNA interaction network
Yunwei Lu, Anna Berenson, … Juan I. Fuxman Bass·Life Science AlliancePeer-reviewed·Jul 16, 2024
- Therapeutic potential of TAF1 bromodomains for cancer treatment
Veronica Garcia-Carpizo, Sergio Ruiz-Llorente, … Maria J. Barrero·bioRxiv·Aug 17, 2018